Anmeldung erfolgt in Kürze...
Details werden geladen...
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report
The FDA wants Amgen's Tavneos off the market. European regulators are investigating data-integrity concerns. And now, a pharma selling the drug in Japan is warning doctors against writing more prescriptions.
Ähnliche Seiten
